• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device surgical cardiac ablation device, for treatment of atrial fibrillation
Definition Surgical cardiac ablation for the treatment of atrial fibrillation.
Product CodeOCM
Device Class 3

Premarket Approvals (PMA)
2019 2020 2021 2022 2023 2024
1 2 1 5 7 1

MDR Year MDR Reports MDR Events
2019 10 10
2020 1 1
2021 6 6
2022 5 5
2023 3 3
2024 2 2

Device Problems MDRs with this Device Problem Events in those MDRs
Adverse Event Without Identified Device or Use Problem 18 18
Defective Device 4 4
Use of Device Problem 2 2
Incorrect, Inadequate or Imprecise Result or Readings 1 1
Appropriate Term/Code Not Available 1 1
Explosion 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
Perforation 6 6
Pulmonary Valve Stenosis 3 3
Cardiac Perforation 3 3
No Known Impact Or Consequence To Patient 3 3
Insufficient Information 2 2
Great Vessel Perforation 2 2
No Consequences Or Impact To Patient 2 2
Cardiac Tamponade 1 1
Hernia 1 1
Stenosis 1 1
Thrombus 1 1
Stroke/CVA 1 1
Hemorrhage/Bleeding 1 1
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 1 1
No Clinical Signs, Symptoms or Conditions 1 1

-
-